Mandatory notification of trade
(Lysaker, Norway, 12 July 2006) Today, Bernt-Olav Røttingsnes, who has been appointed CFO in Navamedic from August, has acquired a total of 6,000 shares in Navamedic ASA.The 6,000 shares were purchased at an average price of NOK 13,27 per share. Mr. Bernt-Olav Røttingsnes has a new holding in Navamedic after the purchase of 6,000 shares. For further information, please contact: Jon W. Ringvold, CFO/IRO E-mail: jon.ringvold@navamedic.com Office: +47 67 11 25 44 Mobile: +47 99 15 85 34 About Navamedic ASA: Navamedic is a Norwegian speciality pharmaceutical company